CUSIP 09071M304SPONSORED ADRBLRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
14 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Citadel Advisors LLC | 36.7K | $104.5K | +26.6K | Added |
| 2 | Rhumbline Advisers | 3.4K | $9.6K | +283 | Added |
| 3 | Citigroup Inc | 2.0K | $5.8K | +2.0K | New |
| 4 | Ubs Group AG | 2.0K | $5.4K | −4.4K |
| Reduced |
| 5 | Wells Fargo & Company/Mn | 1.8K | $4.8K | 0 | Held |
| 6 | Bnp Paribas Financial Markets | 1.5K | $4.2K | +1.5K | New |
| 7 | Nemes Rush Group LLC | 250 | $693 | 0 | Held |
| 8 | Newedge Advisors, LLC | 107 | $296 | 0 | Held |
| 9 | Morgan Stanley | 100 | $277 | −5.9K | Reduced |
| 10 | Osaic Holdings, Inc. | 26 | $71 | +25 | Added |
See every fund holding Bioline Rx Limited, with full quarter-over-quarter share changes.
Unlock all holders